BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2001
View Archived Issues
Wyeth-Ayerst and Taxolog to develop novel taxanes
Read More
Licensing opportunity from NIH: novel vacuolar-type H+-ATPase inhibitors
Read More
Role for donepezil in the prophylaxis of migraine
Read More
Naratriptan superior to naproxen in prevention of menstrual migraine
Read More
New isoniazid derivative is a promising agent for TB
Read More
Susceptibility testing indicates no crossresistance for GAR-936 with other tetracyclines
Read More
Improved stability and in vivo activity achieved in novel human GLP-1 analogues
Read More
Amgen awaits FDA decision on ARANESP
Read More
CLX-090700: a synthetic analogue of a natural product with oral antidiabetic properties
Read More
New study data support lamotrigine as treatment for bipolar disorder
Read More
Pharmacological profile of AS-8112 suggests potential in emesis
Read More
Aphios and ITC/Immune Technology to develop natural therapeutic for hepatitis C
Read More
Corixa updates status of Melacine and Bexxar development programs
Read More
Additional beneficial effects reported for ezetimibe in a hamster model of combined dyslipidemia
Read More
Phytoestrogens attenuate Abeta-mediated neuronal toxicity
Read More
ISTA completes enrollment in second phase III study of Vitrase
Read More
Phytopharm's P-57 successfully completes second stage of obesity study
Read More
FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer
Read More
WHI-P154 claimed for sensitizing cancer cells to radiation
Read More
Several series of antineoplastic agents presented by ADIR in patents
Read More
Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university
Read More
Alkoxyiminoalkanoic acid derivatives for the prevention, treatment of diabetes
Read More
Beta3-adrenoceptor agonists from Fujisawa particularly useful for urinary incontinence, pollakiuria
Read More
Steroid sulfatase inhibitors in development by Novartis for cancer, etc.
Read More